Forest-poppy

Star

Hylomecon japonica

Not yet clinically reviewed

Family: Papaveraceae Genus: Hylomecon Species: japonica

Synonyms: Stylophorum japonicum, Chelidonium japonicum

Forest-poppy
Forest-poppy

Traditionally used for

  • Digestion
  • Pain & joints

Cautions & contraindications

  • Toxic — professional use only
Moderate evidence · 6 studies

Western Herbalism Properties

Actions:
analgesic

Traditional Uses

In Chinese folk medicine and traditional practice the forest poppy (known as hua quan cao) is used: the whole plant is prepared as a remedy for stomach and abdominal pain and for rheumatic joint and muscle pain. The plant contains toxic isoquinoline alkaloids and is regarded as poisonous, so it is used with caution. No North American indigenous use is documented.

Botanical Description

Hylomecon japonica, the forest poppy or wood poppy, is a delicate rhizomatous perennial herb in the poppy family (Papaveraceae), native to the temperate woodlands of eastern Asia including Japan, Korea, northeastern China and the Russian Far East, where it grows in moist, shaded deciduous forest, on humus-rich slopes and along stream banks. It arises from a slender, branching rhizome and reaches 15 to 30 centimetres tall, with soft, sparsely hairy stems that exude a yellow to orange latex when broken. The mostly basal, long-stalked leaves are pinnately divided into several ovate, sharply and irregularly toothed leaflets. In spring it bears solitary or few, bright golden-yellow, four-petalled flowers about 3 to 4 centimetres across on slender stalks, the petals broad and slightly overlapping around a central cluster of numerous stamens. The fruit is a narrow, cylindrical capsule that splits to release the seeds. The plant is grown as a shade-garden ornamental and, like other poppy relatives, contains alkaloid-rich latex.

Native Region: China North-Central, China South-Central, China Southeast, Japan

Active Constituents

6-Methoxydihydrosanguinarine

Benzophenanthridine isoquinoline alkaloid

Concentration: Principal benzophenanthridine of the root and rhizome; isolated from 80 percent ethanol and from methanol extracts

The most-studied single compound of this drug. It inhibits MCF-7 breast carcinoma cells with an IC50 below 20 microM, and in MCF-7 it accumulates reactive oxygen species and suppresses PI3K/AKT/mTOR signalling, inducing both apoptosis and autophagy. It also blocks Candida albicans filamentation and biofilm formation by downregulating the cAMP pathway genes EFG1, CDC35, RAS1 and TPK2.

Protopine

Protopine-type isoquinoline alkaloid

Concentration: Reported as the most abundant alkaloid recovered by acid-base total alkaloid extraction of the root

Antibacterial against Gram-positive organisms in TLC-bioautography screening of the root alkaloids. Protopine is roughly ten to twenty times less cytotoxic than the quaternary benzophenanthridines that accompany it, so it is not the drug's dose-limiting toxin.

Sanguinarine

Quaternary benzophenanthridine alkaloid

Concentration: Root; a minor constituent relative to its dihydro and 6-substituted derivatives

A broadly cytotoxic quaternary alkaloid and, with chelerythrine and coptisine, one of the constituents identified by LC-MS/MS intracellular-accumulation screening as responsible for the hepatocellular toxicity of the related Papaveraceae drug Chelidonium majus. Its presence is the main reason this root should not be treated as a bland folk remedy.

Chelerythrine

Quaternary benzophenanthridine alkaloid

Concentration: Root; present alongside a large family of 6-substituted dihydrochelerythrine derivatives

A protein kinase C inhibitor that causes growth arrest or death in most mammalian cell lines, and one of the alkaloids implicated in Chelidonium majus liver injury. It also inhibits mitochondrial NADH and succinate dehydrogenase in the same experimental systems.

Dihydrosanguinarine

Dihydrobenzophenanthridine isoquinoline alkaloid

Concentration: Root

One of the antibacterial alkaloids of the root, active mainly against Gram-positive bacteria. It is also one of the two components proposed to carry the anti-inflammatory activity of Hylomecon methanol extracts through downregulation of ERK1/2 and p38 phosphorylation.

Allocryptopine

Protopine-type isoquinoline alkaloid

Concentration: Root and rhizome; isolated together with cryptopine and protopine

A minor alkaloid shared with Chelidonium majus and Macleaya cordata. In Chelidonium studies it contributes to inhibition of hepatic mitochondrial respiration, so it is best read as part of the drug's cumulative alkaloid burden rather than as a therapeutic principle.

Hylomeconoside A

Oleanane-type triterpenoid saponin

Concentration: Whole herb; one of more than twenty hylomeconoside saponins reported from this species

Moderately cytotoxic to MGC-803 gastric carcinoma and HL-60 promyelocytic leukaemia cells in the 30 to 45 microgram per millilitre range. Saponins of this series are glycosides of gypsogenin and quillaic acid, the same aglycones that carry the adjuvant and haemolytic activity of Quillaja saponins.

Hylomeconoside J

Oleanane-type triterpenoid saponin

Concentration: Whole herb

The most potent of the screened monomer saponins against AGS gastric adenocarcinoma cells, with an IC50 of 6.01 microM, inducing apoptosis dose-dependently. Most of the other hylomeconosides were inactive over 10 to 100 microM, so activity in this series is structure-specific rather than a general saponin effect.

⚠ Drug Interactions

Chelidonium majus (Bai Qu Cai)

Moderate Evidence: Probable

Both drugs are Papaveraceae roots carrying the same quaternary benzophenanthridine alkaloids, sanguinarine and chelerythrine, plus protopine and allocryptopine. Sanguinarine, chelerythrine and coptisine are the constituents identified as the hepatotoxic components of Chelidonium majus, and Chelidonium is the subject of causality-assessed spontaneous reports of herb-induced liver injury. The East Asian article is often supplied as Chelidonium asiaticum, which is a variety of Chelidonium majus and carries the same alkaloids. No hepatotoxicity study has been published on Hylomecon japonica itself, so the concern is inferred from shared chemistry rather than measured in this species.

Clinical note: Do not combine the two in one formula, and do not use either as a substitute for the other without recalculating the total alkaloid dose. Check baseline liver enzymes and repeat them if use runs beyond a few weeks.

Macleaya cordata (Bo Luo Hui)

Moderate Evidence: Probable

Macleaya cordata is the commercial source of sanguinarine and chelerythrine and is a recognised toxic drug used almost entirely externally. Hylomecon japonica carries the same two alkaloids. Co-administration stacks the same quaternary benzophenanthridine exposure from two directions without any pharmacological rationale for doing so.

Clinical note: Avoid the combination. If Bo Luo Hui is being applied topically over broken skin, treat that as systemic exposure when a Hylomecon-containing internal formula is also in use.

Hepatotoxic drugs such as methotrexate, isoniazid and azole antifungals

Theoretical Evidence: Theoretical

Extrapolated from the alkaloid class, not measured for this herb. The benzophenanthridines and protopine alkaloids present here inhibit hepatic mitochondrial NADH and succinate dehydrogenase in vitro, and the same alkaloids account for the hepatotoxicity of Chelidonium majus. There are no pharmacokinetic, hepatic-safety or drug-metabolism data for Hylomecon japonica in humans at all.

Clinical note: Treat concurrent use with a known hepatotoxin as a reason to monitor transaminases, and stop the herb first if they rise.

Coreanomecon hylomeconoides, formerly Hylomecon hylomeconoides

Theoretical Evidence: Probable

This is a sourcing hazard rather than a pharmacological interaction. Two of the most-cited pharmacology papers attached to Hylomecon japonica in review articles actually used Hylomecon hylomeconoides, a Korean endemic now placed in the segregate genus Coreanomecon: the 2010 anti-MRSA study and the 2012 RAW 264.7 anti-inflammatory study. The 2004 report that 6-methoxydihydrosanguinarine kills HT29 colon carcinoma cells likewise isolated the compound from that species. The compound itself is genuinely present in Hylomecon japonica, but the extract-level activity claims are not this species' data.

Clinical note: When citing antibacterial or anti-inflammatory evidence for this herb, check which Hylomecon was actually assayed. Do not accept a supplier's antimicrobial claim that traces back to the Korean species.

Dosage Calculator

⚖ Dosage Calculator

A weight-based mathematical estimate for Forest-poppy. Not a prescription.

Evidence Tier

Moderate evidence · 6 studies

Recorded studies by study design, strongest design at the top. This is a study-design tier only, not a GRADE rating: it does not weigh risk of bias, consistency or precision.

Verified: design read from PubMed for a DOI that resolves to the cited paper Unverified: taken from the study's recorded description

Clinical Studies

Isoquinoline alkaloids from Hylomecon japonica and their potential anti-breast cancer activities

Cao Z, Zhu S, Xue Z, Zhang F, Zhang L, Zhang Y, Guo Y, Zhan G, Zhang X, Guo Z (2022) Phytochemistry in vitro

Twenty-six isoquinoline alkaloids, nine of them previously undescribed, were isolated from the roots and rhizomes and tested against MCF-7 breast cancer cells. Eight, including 6-methoxydihydrosanguinarine and several 6-substituted dihydrochelerythrines, inhibited MCF-7 with IC50 below 20 microM. This is a cell-line screen with no normal-cell comparator reported in the abstract, so it establishes chemistry and cytotoxicity, not therapeutic selectivity.

6-Methoxydihydrosanguinarine induces apoptosis and autophagy in breast cancer MCF-7 cells by accumulating ROS to suppress the PI3K/AKT/mTOR signaling pathway

Zhang L, Zhang X, Che D, Zeng L, Zhang Y, Nan K, Zhang X, Zhang H, Guo Z (2023) Phytotherapy Research in vitro

Network pharmacology plus cell work in MCF-7. The alkaloid raised reactive oxygen species, inhibited PI3K/AKT/mTOR signalling and induced both apoptosis and autophagy; N-acetylcysteine reversed the effects and the PI3K inhibitor LY294002 amplified them. Entirely in vitro, in one cell line, with no animal or human component.

TLC Bioautography-guided Isolation and Antimicrobial, Antifungal Effects of 12 Alkaloids from Hylomecon japonica Roots

Xue X, Zhang H, Zhang X, Liu X, Xi K, Han Y, Guo Z (2017) Natural Product Communications in vitro

Bioautography-guided isolation from the roots of this species, so the taxonomy is sound. Twelve alkaloids were assayed against Staphylococcus aureus, Candida albicans, Pseudomonas aeruginosa and Escherichia coli. Activity ranked benzophenanthridine isoquinoline alkaloids above steroid alkaloids above protoberberine alkaloids, with the strongest effects against Gram-positive organisms. Broth and plate work only.

Bioactive oleanane-type saponins from Hylomecon Japonica

Li F, Wu S, Qu M, Wang Y, Ma C, Yu B, Wang G (2021) Phytochemistry in vitro

Six undescribed oleanane saponins, hylomeconosides L to Q, from the whole herb, characterised as gypsogenin and quillaic acid glycosides. They showed selective cytotoxicity across A549, AGS, HeLa, Huh7, HT29 and K562 lines. Useful for identifying the saponin aglycones, which are the same ones that make Quillaja saponins haemolytic; it says nothing about oral efficacy.

Discovery of novel adjuvants: Identification of saponins from Hylomecon japonica (Thunb.) Prantl & Kündig and insights into their in vitro and in vivo activities.

Shi P, Zhao L, Zhang M, Zhao J, Niu J, Zhai J, Yin J (2025) Bioorganic Chemistry animal Verified: In vitro / animal

Fourteen triterpenoid saponins were isolated from the herb and screened for immune-adjuvant activity. One new saponin promoted proliferation and phagocytosis in spleen lymphocytes, DC2.4 and RAW 264.7 cells, and in immunised mice raised specific serum antibody, Th1 and Th2 cytokines and dendritic cell maturation via TLR4/MyD88/NF-kB. A mouse adjuvant study, not a therapeutic trial, and the relevance to an oral decoction of the crude root is unestablished.

Effects of Hylomecon vernalis ethanol extracts on cell cycle and apoptosis of colon cancer cells

Sun J, Zhang X, Sun Y, Tang Z, Guo D (2017) Molecular Medicine Reports in vitro

Published under the synonym Hylomecon vernalis. An ethanol extract that was 89.67 percent alkaloid by HPLC-MS inhibited HT-29 and SW620 colon cancer cells with IC50 of 0.105 and 0.146 milligrams per millilitre, arrested cells in G1 and shifted caspase-3, caspase-9 and Bcl-2 expression. Cell culture only. The very high alkaloid fraction is also a reminder of how concentrated an ethanol extract of this root is compared with a water decoction.

Historical Texts

Medicinal Plant Flora of Tianmu Mountain in Zhejiang Province (Zhejiang Tianmushan Yaoyongzhiwuzhi)

1965, Health Bureau of Zhejiang Province
One of the earliest published records of the drug. This is a twentieth-century regional survey, not a classical materia medica: the herb has no entry in the Han-to-Qing canon.

Herbal Medicines of Shaanxi (Shaanxi Zhongcaoyao)

1971, Science Press, Beijing, pages 500 to 501
Records the Taibai Mountain drug name Guaizaoqi. Cites the plant under the synonym Hylomecon vernalis Maxim., a name the modern literature has since set aside in favour of Hylomecon japonica.

National Compilation of Chinese Herbal Medicines (Quanguo Zhongcaoyao Huibian)

1975, People's Medical Publishing House
The national folk-medicine compilation that carried the drug beyond Shaanxi and Zhejiang. The rhizome is the part specified; the whole plant is a secondary, lesser-used article.

A Record of Medicinal Herbs on Mount Hua (Huashan Yaowuzhi)

1985, Shaanxi Science and Technology Publishing House, page 277
Places the drug in the Qinling qi yao tradition of Mount Taibai and Mount Hua, where it is used for the five overstrains and seven injuries, that is chronic depletion from overwork and injury.

Chinese Materia Medica (Zhonghua Bencao)

1999, Shanghai Scientific and Technical Publishers, pages 2269 to 2270
The standard modern compendium entry. Functions given are to disperse blood stasis and swelling, relax the sinews, quicken the blood, relieve pain, stop bleeding and dispel wind, cold and damp; indications are wind-cold-damp bi, rheumatic joint pain, traumatic injury, taxation fatigue, limb weakness, epigastric pain and dysentery.

References

  1. Tian Y, Xia G, Zhu J, Li L, Zang H. Hylomecon japonica: A Review About Botanical Aspects, Traditional Applications, Chemical Composition, and Pharmacological Properties . Horticulturae (2025) [DOI]
  2. Wang M, Shi P, Zhang M, Han N. Chemical Constituents and Biological Activities of the Hylomecon japonica (Thunb.) Prantl & Kündig – A Comprehensive Review . Chemistry & Biodiversity (2024) [DOI]
  3. Itokawa H, Ikuta A, Tsutsui N, Ishiguro I. Alkaloids and a sterol from Chelidonium japonicum . Phytochemistry (1978) [DOI]
  4. Li X, Sun Y, Wang M, Wang Z, Kuang H. Alkaloids in Chelidonium majus L: a review of its phytochemistry, pharmacology and toxicology . Frontiers in Pharmacology (2024) [DOI]
  5. Wu C, Wang X, Xu M, Liu Y, Di X. Intracellular Accumulation as an Indicator of Cytotoxicity to Screen Hepatotoxic Components of Chelidonium majus L. by LC-MS/MS . Molecules (2019) [DOI]
  6. Zhang M, Yang J, Sun Y, Kuang H. Recent Advances in Alkaloids from Papaveraceae in China: Structural Characteristics and Pharmacological Effects . Molecules (2024) [DOI]

This information is for educational purposes only and is not intended to replace professional medical advice. Always consult a qualified healthcare provider before using any herbal remedy, especially if you are pregnant, nursing, or taking medications.

📝 Notes

Public notes from the community and your own private notes on Forest-poppy.

No notes yet.

Log in or register to add your own notes.

Back to Herb Database